Pharm of Asthma - Fitzpatrick Flashcards
Immune players in asthma (4)
Mast cells, dendritic cells, eosinophils, Th2 cells
Smooth muscle constriction of bronchioles
Airway inflammation, mucus, pulmonary edema
Asthma
Asthma drug type used ONLY acutely/urgently to relieve symptoms
Short-acting Beta-2 agonists (SABAs) - usually inhaled
2 classes of asthma CONTROLLER drugs (daily use)
- Anti-inflammatory
- Bronchodilators
3 classes of anti-inflammatory agents for asthma prevention
- Corticosteroids
- LT modifiers
- Anti-IgE antibody
2 classes of bronchodilator agents for asthma prevention
- Long acting beta-2 agonists
- Anti-cholinergic agents
When to start using a daily controller drug for asthma
What drug type?
> 2 attacks per week
Low dose inhaled corticosteroid (ICS)
If DAILY asthma attacks…treat with what controllers daily?
Medium dose ICS + long-acting beta-2 agonist (LABA)
Should SABAs and controller drugs be used together?
YES - always use a SABA to relieve a current attack even if already on a controller drug
If a trigger of asthma symptoms can be predicted, when should the patient take the SABA?
10 minutes prior to symptom onset
Should epinephrine be used for asthma attacks?
NO - don’t want the beta-1 effects on the cardiac muscle
5 SABAs (relievers)
- Albuterol
- Levalbuterol
- Pirbuterol
- Metaproterenol
- Terbutaline
2 LABAs (controllers)
- Salmeterol
- Formoterol
Drugs contraindicated in asthma patients
Beta-2 antagonists (propranolol, nadolol, timolol, pindolol)
If you are using more than _____ SABA per month, your asthma is not adequately controlled, and you should consider a controller drug
1 canister
5 ICS drugs (controllers)
- Beclomethasone
- Triamcinolonoe
- Flunisolide
- Budesonide
- Fluticasone
Function of corticosteroids (molecular/cellular)
Receptors dimerize –> become Txn factor –> express anti-inflammatory genes and suppres inflammatory genes
ICS time of onset
Several hours to days (must wait for gene Txn)
Benefits of ICS use
- Fewer symptoms, exacerbations
- Less use of SABAs
- Improved lung function (FEV1)
- Reduced airway inflammation
Inhaled ICSs are designed to minimize _____
Systemic exposure, unwanted side effects